TABLE 2.

The clinical significance of six plasma exosomal miRNA in distinguishing mTLE + HS from mTLE−HS controls.

Exosomal miRNA	Cutoff	p-Value	AUC	Sensitivity	Specificity	95% CI
hsa-miR-129-5p	5.34	0.016	0.735	0.722	0.722	0.565–0.904
hsa-miR-214-3p	5.28	5.49 × 10–5	0.894	0.833	0.778	0.793–0.994
hsa-miR-219a-5p	5.32	0.033	0.708	0.778	0.556	0.539–0.878
hsa-miR-34c-5p	5.94	0.007	0.764	0.667	0.778	0.607–0.920
hsa-miR-421	5.77	1.29 × 10–4	0.873	0.778	0.889	0.761–0.986
hsa-miR-184	6.27	1.46 × 10–5	0.923	0.889	0.833	0.819–1.000